KV-A Financial Facts

Diluted shares outstanding - Class A common: 59.9M
Net income (loss): -37.8M
See Full Income Statement

See Full Balance Sheet

K-V Pharmaceutical (KV-A) Earnings

  |   Expand Research on KV-A
Next EPS Date N/A EPS Growth Rate N/A
Average EPS % Beat Rate N/A Revenue Growth Rate N/A
Average % Move 1-Wk after EPS N/A Normal Earnings Time N/A
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
6/14/12 Q412 -$0.54N/A N/A N/AN/A N/A Details